VBI Vaccines
VBIV
#10522
Rank
HK$14.6 M
Marketcap
HK$0.51
Share price
0.00%
Change (1 day)
-89.28%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): -HK$79.49

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is -HK$79.06. In 2022 the company made an earnings per share (EPS) of -HK$102.92 a decrease over its 2021 EPS that were of -HK$63.15.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-HK$79.49
2022-HK$102.9262.96%
2021-HK$63.1528.57%
2020-HK$49.12-54.35%
2019-HK$107.59-52.58%
2018-HK$226.8810.23%
2017-HK$205.8314.29%
2016-HK$180.10-62.8%
2015-HK$484.1790.68%
2014-HK$253.92-7.95%
2013-HK$275.87-57.97%
2012-HK$656.42-78%
2011-HK$2,9843151.47%
2010-HK$91.7823.87%
2009-HK$74.10-18.48%
2008-HK$90.9012.08%
2007-HK$81.10-49.47%
2006-HK$160.51
2005N/A-100%
2004-HK$71.3511.94%
2003-HK$63.74-81.89%
2002-HK$351.97196.44%
2001-HK$118.7384.33%
2000-HK$64.41-65.37%
1999-HK$186.01-29.45%
1998-HK$263.6429.61%
1997-HK$203.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-HK$7.41-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-HK$33.76-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-HK$28.61-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA